Urological Devices – Market Insights – Europe

The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH devices—especially Aquablation, and UI devices. Additional market drivers include rising obesity rates, premium device adoption, and broader access to less-invasive treatments. However, reimbursement challenges, litigation risks tied to genitourinary meshes, and healthcare budget constraints will limit uptake of newer, premium-priced technologies.

This Medtech 360 Report provides comprehensive data and analysis on the of the market for urological devices in Europe from 2019 through 2034.

Ongoing clinical studies and research continue to affect procedure trends, and thus device adoption trends.

What do recent studies indicate regarding the outlook of existing techniques for treating prostate cancer and BPH?

What upcoming novel treatments are expected to compete with existing methods of treatment?

Mergers and acquisitions have been altering the competitive landscape.

What are the most relevant recent acquisitions affecting the market?

How will market shares and product portfolios be affected as a result of these acquisitions?

Minimally invasive treatment volumes will increase in Europe over the forecast period.

What factors contribute to the increase of minimally invasive treatments?

How have minimally invasive treatment options changed the BPH device market?

Which market segments will see the greatest adoption of minimally invasive treatments?

What is the impact of Aquablation on the Europe urological device market?

UI device segment represents a significant proportion of the overall market revenues.

What factors impact the use of UI devices?

How will the change in ASPs of UI devices affect the market?

Premium devices and their adoption will influence market trends.

Which device markets are going to be affected by preference for premium variants of devices?

What circumstances hinder the uptake of premium devices in the European region?

Some market segments are being negatively impacted by product safety concerns.

Which market segments are being impacted by safety concerns?